REG - Stock Exch Notice Argent Biopharma Ltd - Cancellation - Argent Biopharma Limited

Argent BioPharmaAnnouncement

31/12/2024 08:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241231:nRSe6451Ra&default-theme=true

RNS Number : 6451R  London Stock Exchange Notice  31 December 2024

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE

 

31/12/2024 - 08:00

 

At the request of the company the following securities have been cancelled
from admission to trading on London Stock Exchange with effect from the time
and date of this notice.

 

 ARGENT BIOPHARMA LIMITED
 213800HRE3FQJ6RK4H10
 ORDINARY SHARES OF NO PAR VALUE, FULLY PAID (DI)  (BPSKPP6)(AU0000326647)  ARGENTBIO/ORD UNRESTR NPV

 

If you have any queries relating to the above, please contact Market
Operations at the London Stock Exchange on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  SENBUBDDUUXDGSG